3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
3
Neoplasms
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Ovarian Neoplasms
1
Neoplasms, Second Primary
1
NSCLC
1
Lung Neoplasms
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Biphenotypic, Acute
1
Kidney Neoplasms
1
Gastro Intestinal Stromal Tumor
1
Endometrial Neoplasms
1
Congenital Abnormalities
1
Asymptomatic Brain Metastases
1
Interventions
Whole-Body Irradiation
4
Peripheral Blood Stem Cell Transplantation
4
Etoposide
4
Busulfan
4
fludarabine phosphate
3
Mycophenolic Acid
3
Cyclophosphamide
3
Transplantation
2
Tacrolimus
2
Sirolimus
2
Melphalan
2
Cyclosporine
2
fludarabine
1
aldesleukin
1
Whole Genome Sequencing
1
Valganciclovir
1
Tyrosine Kinase Inhibitors
1
Tissue Banks
1
Therapeutics
1
Self Care
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiography, Panoramic
1
Positron-Emission Tomography
1
Polymerase Chain Reaction
1
Patient Reported Outcome Measures
1
Methotrexate
1
Idarubicin
1
Ganciclovir
1
Foscarnet
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Congenital Abnormalities
×
Tyrosine Kinase Inhibitors
×
1 year
×
Clear all
NCT04151342
2025-12-03
CARMA-BROS
University Health Network, Toronto
Recruiting
5,500 enrolled